Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,128 | 134,697 | 155,464 | 193,389 | 156,172 |
| Marketable Securities | 331,631 | 241,289 | 294,420 | 317,655 | 303,479 |
| Receivables | 7,321 | 9,131 | 9,468 | 11,050 | 11,353 |
| TOTAL | $527,832 | $466,449 | $527,711 | $581,941 | $495,945 |
| Non-Current Assets | |||||
| PPE Net | 15,058 | 15,516 | 17,671 | 20,421 | 22,806 |
| Investments And Advances | 228,320 | 179,271 | 190,790 | 158,814 | 170,855 |
| Other Non-Current Assets | 85,954 | 97,543 | 105,955 | 164,099 | 209,288 |
| TOTAL | $329,332 | $292,330 | $314,416 | $343,334 | $402,949 |
| Total Assets | $857,164 | $758,779 | $842,127 | $925,275 | $898,894 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,714 | 18,800 | 20,252 | 13,260 | 9,802 |
| Accrued Expenses | 44,334 | 37,920 | 49,862 | 40,841 | 41,553 |
| TOTAL | $79,392 | $76,445 | $103,884 | $93,726 | $95,499 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 630 | 7,290 | 12,247 | 17,154 |
| Other Non-Current Liabilities | 50,066 | 61,395 | 66,849 | 70,588 | 75,601 |
| TOTAL | $50,066 | $61,395 | $66,849 | $83,127 | $88,140 |
| Total Liabilities | $129,458 | $137,840 | $170,733 | $176,853 | $183,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 140,127 | 139,722 | 118,134 | 115,830 | 107,347 |
| Common Shares | 14 | 12 | 12 | 12 | 10 |
| Retained earnings | -2,792,959 | -2,686,325 | -2,590,094 | -2,494,308 | -2,392,984 |
| Other shareholders' equity | -1,030 | -240 | 1,032 | 990 | 653 |
| TOTAL | $727,706 | $620,939 | $671,394 | $748,422 | $715,255 |
| Total Liabilities And Equity | $857,164 | $758,779 | $842,127 | $925,275 | $898,894 |